PRZOOM - Newswire - Press Release Distribution - Pharma / BioTech / Nutrition https://www.przoom.com/ Recent Pharma / BioTech / Nutrition - PRZOOM Press Releases - NewswireToday Headline News - Visit PressReleaseNewswireDistribution.com Mon, 13 Apr 2026 11:06:09 -0400 Pharma / BioTech / Nutrition rss20 by https://www.przoom.com/ newsfeed_888@przoom.com Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan PRZOOM - Newswire (press release) - Thu, 26 Mar 2026 00:00:00 -0400, Osaka, Japan - Ono Pharmaceutical Co., Ltd announced that Ono submitted an application for the manufacturing and marketing approval of ripretinib (DCC-2618), developed by Deciphera Pharmaceuticals, Inc. - Deciphera.com / ONO-Pharma.com https://www.przoom.com/news/185930/ Thu, 26 Mar 2026 00:00:00 -0400 Pharma / BioTech / Nutrition Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition PRZOOM - Newswire (press release) - Wed, 25 Mar 2026 00:00:00 -0400, San Antonio, TX United States - The company is acknowledged for its scalable technology platform, application diversity, and customer-centered commercialization driving multi-industry adoption - LocusFS.com https://www.przoom.com/news/185923/ Wed, 25 Mar 2026 00:00:00 -0400 Pharma / BioTech / Nutrition Ipsen Showcases Transformative Potential of Early Immuno-oncology Pipeline At AACR PRZOOM - Newswire (press release) - Wed, 18 Mar 2026 00:00:00 -0400, Paris, Île-de-France France - Ipsen announced today the presentation of new preclinical data across multiple early development programs currently in Phase I clinical trials, at the American Association of Cancer Research (AACR) congress - AACR.org / Ipsen.com https://www.przoom.com/news/185870/ Wed, 18 Mar 2026 00:00:00 -0400 Pharma / BioTech / Nutrition Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology PRZOOM - Newswire (press release) - Tue, 03 Mar 2026 00:00:00 -0500, Osaka, Japan - Ono Pharmaceutical Co., Ltd announced that it has entered into an agreement to expand the drug discovery collaboration agreement with Congruence Therapeutics Congruencetx.com / ONO-Pharma.com https://www.przoom.com/news/185763/ Tue, 03 Mar 2026 00:00:00 -0500 Pharma / BioTech / Nutrition Ono Pharma Announces Transfer of the Manufacturing and Marketing Approval Authorization for Opalmon® Tablets and Prostandin® Ointment PRZOOM - Newswire (press release) - Mon, 02 Mar 2026 00:00:00 -0500, Osaka, Japan - Ono Pharma Announces Transfer of the Manufacturing and Marketing Approval Authorization for Opalmon® Tablets and Prostandin® Ointment to Daito Pharmaceutical Co., Ltd - Daitonet.co.jp / ONO-Pharma.com https://www.przoom.com/news/185750/ Mon, 02 Mar 2026 00:00:00 -0500 Pharma / BioTech / Nutrition Ono Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory PRZOOM - Newswire (press release) - Mon, 16 Feb 2026 00:00:00 -0500, Osaka, Japan - Ono Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory PCNSL - NavigatingPCNSL.com / ONO-Pharma.com https://www.przoom.com/news/185650/ Mon, 16 Feb 2026 00:00:00 -0500 Pharma / BioTech / Nutrition SCHOTT Pharma Launches EVERIC® Lyo & Amber Vials for Light-sensitive ADCs PRZOOM - Newswire (press release) - Thu, 22 Jan 2026 00:00:00 -0500, Mainz, Germany - SCHOTT Pharma, a pioneer in drug containment solutions and delivery systems, is expanding its EVERIC® specialty vial portfolio with a new amber-colored option made from FIOLAX® amber pharma glass - SCHOTT-Pharma.com https://www.przoom.com/news/185504/ Thu, 22 Jan 2026 00:00:00 -0500 Pharma / BioTech / Nutrition Arbitration Tribunal Upholds Ipsen’s Termination of R&D Agreement with Galderma PRZOOM - Newswire (press release) - Wed, 21 Jan 2026 00:00:00 -0500, Paris, Île-de-France France - The ICC Tribunal’s decision confirms Ipsen’s full rights to its clinical stage toxin programs in the aesthetic field - ICCwbo.org / Galderma.com / Ipsen.com https://www.przoom.com/news/185492/ Wed, 21 Jan 2026 00:00:00 -0500 Pharma / BioTech / Nutrition New Data Reinforces Ipsen’s Commitment to Bringing Solutions and Addressing Care Gaps in Neurological Diseases At TOXINS PRZOOM - Newswire (press release) - Thu, 15 Jan 2026 00:00:00 -0500, Paris, Île-de-France France - Ipsen announced today the presentation of 14 across multiple neurological conditions at the TOXINS 2026 conference (14-17 January) in Madrid, Spain - NeuroToxins.org / Ipsen.com https://www.przoom.com/news/185458/ Thu, 15 Jan 2026 00:00:00 -0500 Pharma / BioTech / Nutrition Opdivo® Intravenous Infusion Approved in Taiwan in Combination with Yervoy® for the Treatment of Adult Patients PRZOOM - Newswire (press release) - Wed, 14 Jan 2026 00:00:00 -0500, Osaka, Japan - Opdivo® Intravenous Infusion Approved in Taiwan in Combination with Yervoy® for the Treatment of Adult Patients with Unresectable or Metastatic Microsatellite Instability-High or Mismatch Repair Deficient Colorectal Cancer - BMS.com / ONO-Pharma.com https://www.przoom.com/news/185438/ Wed, 14 Jan 2026 00:00:00 -0500 Pharma / BioTech / Nutrition U.S. FDA Grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in First Line Unfit Acute Myeloid Leukemia PRZOOM - Newswire (press release) - Tue, 13 Jan 2026 00:00:00 -0500, Paris, Île-de-France United States - Breakthrough Therapy Designation granted for investigational therapy IPN60340 in combination with venetoclax and azacitidine in first line unfit acute myeloid leukemia - FDA.gov / Ipsen.com https://www.przoom.com/news/185433/ Tue, 13 Jan 2026 00:00:00 -0500 Pharma / BioTech / Nutrition Additional Approval of Combination Therapy with BRAFTOVI® Capsule, a BRAF Inhibitor, for the Indication of Colorectal Cancer in South Korea PRZOOM - Newswire (press release) - Tue, 13 Jan 2026 00:00:00 -0500, Osaka, Japan - This approval is based on the results of a global multicenter, Phase 3 BREAKWATER study (ONO-7702-03/C4221015) - Braftovi.com / Pfizer.com / ONO-Pharma.com https://www.przoom.com/news/185426/ Tue, 13 Jan 2026 00:00:00 -0500 Pharma / BioTech / Nutrition BostonGene Recognized by Frost & Sullivan for 2025 Global Technology Innovation Leadership in AI-Driven Precision Oncology Solutions PRZOOM - Newswire (press release) - Mon, 12 Jan 2026 00:00:00 -0500, San Antonio, TX United States - Reshaping the Global Drug Development Landscape with the Industry’s Only Natively AI-Powered Omnimodal Foundation Model for Tumor and Immune Biology - BostonGene.com https://www.przoom.com/news/185422/ Mon, 12 Jan 2026 00:00:00 -0500 Pharma / BioTech / Nutrition Ipsen Expands Early Development Pipeline with Simcere Zaiming’s Innovative Antibody Drug Conjugate PRZOOM - Newswire (press release) - Mon, 22 Dec 2025 00:00:00 -0500, Paris, Île-de-France France - Ipsen announced today an exclusive licensing agreement for global rights outside of Greater China, for SIM0613, an antibody-drug conjugate (ADC) with best-in-class potential - Simcere.com / Ipsen.com https://www.przoom.com/news/185355/ Mon, 22 Dec 2025 00:00:00 -0500 Pharma / BioTech / Nutrition Ipsen Update on Phase II FALKON Trial in Patients with Ultra-rare Bone Disease, Fibrodysplasia Ossificans Progressiva (FOP) PRZOOM - Newswire (press release) - Fri, 19 Dec 2025 00:00:00 -0500, Paris, Île-de-France France - The investigational medicinal product (fidrisertib) was generally well tolerated, with no safety concerns in the trial - Ipsen.com https://www.przoom.com/news/185345/ Fri, 19 Dec 2025 00:00:00 -0500 Pharma / BioTech / Nutrition